Page 7 - Shimadzu Technologies for COVID-19 Crisis

Hydroxychloroquine and Ivermectin Analysis

Medical researchers are racing against time to develop new drugs and treatments for COVID-19 .
They are also investigating the possibility of using existing available medicines. Some of the
potential drugs include hydroxychloroquine and ivermectin.

Apart from studying the efficacy of these drugs towards COVID-19, the quality of drugs is as
crucial. Quality with reliable operations and high productivity can be achieved during this period
through Shimadzu analytical instruments and informatics solutions.

i-Series Plus
Most robust platform to meet high pressing quality needs of
assay and related impurity methods as per pharmacopoeia

innovative Advanced interactive design

intuitive Easy operation

intelligent Smart features for high productivity

Nexis GC-2030
Together with headspace HS-20, this simple setup
is the optimal platform for residual solvent analysis
based on USP-467.

• Low helium gas consumption ensures long
unattended operations for maximum throughput
• Minimal carryover with super short headspace

transfer line

Informatics Solutions
Wide range of informatics solutions to
address your laboratory challenges
• Fast and easy analysis setup with remote access
• Safe and secure data management

• Efficient workflows and consolidated reporting
• Total support for regulatory compliance

Shimadzu and Alsachim are supporting these drug development
and clinical trials by providing internal standards for therapeutic
drug monitoring of these potential anti-COVID-19 drugs.

7